Anvisa approves new Covid-19 vaccine
The covid-19 (recombinant) immunizing zika vaccine with s-protein and saponin-based adjuvant has been approved.
Anvisa publishes new edition of the Biosurveillance Manual
The document provides guidelines on monitoring adverse events in transplants, grafts and assisted human reproduction.
Brazil to be present at 15 global food fairs in 2023
MAPA aims to boost national agribusiness, taking advantage of opportunities to promote Brazilian products on the market.
Anvisa approves new treatment for advanced cancer in Brazil
Anvisa has approved a gene therapy drug to treat hematologic cancer (gene therapy using patients’ genetically modified T cells).
Anvisa allows use of packaging and label reserves
The impacts of the pandemic prompted the decision due to logistical challenges and variations in purchasing power in the food sector.
Updating the Brazilian Pharmacopoeia
As of January 2, 2024, companies have 180 days from the date the standard comes into force to adapt their procedures.
Joint operation to combat illegal imports
Anvisa and Receita Federal inspect luggage to identify illegal imports of products subject to health surveillance.
Cofepris facilitates access to innovative medicines
Cofepris has taken important steps to facilitate the population’s access to high-quality biotechnologicals and biosimilars.
Viminol is now a controlled substance
The drug Viminol must be dispensed with a doctor’s prescription and by pharmacies using Prescription Notification A (yellow).
MАРА inspects trade in smuggled wines
MAPA and the State Secretariat for Agriculture, Livestock and Irrigation carried out an enforcement action targeting the wine trade.